Mary E. Heber

660 total citations
29 papers, 502 citations indexed

About

Mary E. Heber is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Complementary and alternative medicine. According to data from OpenAlex, Mary E. Heber has authored 29 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cardiology and Cardiovascular Medicine, 14 papers in Surgery and 6 papers in Complementary and alternative medicine. Recurrent topics in Mary E. Heber's work include Blood Pressure and Hypertension Studies (14 papers), Cardiovascular Syncope and Autonomic Disorders (7 papers) and Cardiovascular and exercise physiology (6 papers). Mary E. Heber is often cited by papers focused on Blood Pressure and Hypertension Studies (14 papers), Cardiovascular Syncope and Autonomic Disorders (7 papers) and Cardiovascular and exercise physiology (6 papers). Mary E. Heber collaborates with scholars based in United Kingdom and Canada. Mary E. Heber's co-authors include Royce P Vincent, Alfred L. Aronson, R.M. Grainger, N S V Jaggarao, D A Chamberlain, Avijit Lahiri, M. Caruana, Edward B. Raftery, D. A. Chamberlain and E. B. Raftery and has published in prestigious journals such as The Lancet, Hypertension and Journal of Educational Psychology.

In The Last Decade

Mary E. Heber

29 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary E. Heber United Kingdom 12 234 119 114 46 38 29 502
G. Hempelmann Germany 16 261 1.1× 84 0.7× 476 4.2× 50 1.1× 33 0.9× 154 936
Willehad Boemke Germany 16 183 0.8× 85 0.7× 143 1.3× 69 1.5× 23 0.6× 74 804
Leonard C. Jenkins Canada 18 156 0.7× 75 0.6× 295 2.6× 47 1.0× 25 0.7× 77 780
D. Emslie-Smith United Kingdom 16 237 1.0× 129 1.1× 80 0.7× 57 1.2× 54 1.4× 44 721
A A McLeod United Kingdom 14 349 1.5× 49 0.4× 100 0.9× 83 1.8× 35 0.9× 24 624
P Huguenard France 9 105 0.4× 85 0.7× 74 0.6× 54 1.2× 31 0.8× 52 436
John C. Mithoefer United States 20 173 0.7× 113 0.9× 108 0.9× 69 1.5× 46 1.2× 52 900
K Steinbereithner Austria 12 115 0.5× 105 0.9× 127 1.1× 97 2.1× 36 0.9× 100 473
Stephen M. Koch United States 12 47 0.2× 106 0.9× 121 1.1× 90 2.0× 48 1.3× 24 691
Leonard F. Walts United States 20 155 0.7× 35 0.3× 293 2.6× 78 1.7× 31 0.8× 54 815

Countries citing papers authored by Mary E. Heber

Since Specialization
Citations

This map shows the geographic impact of Mary E. Heber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary E. Heber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary E. Heber more than expected).

Fields of papers citing papers by Mary E. Heber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary E. Heber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary E. Heber. The network helps show where Mary E. Heber may publish in the future.

Co-authorship network of co-authors of Mary E. Heber

This figure shows the co-authorship network connecting the top 25 collaborators of Mary E. Heber. A scholar is included among the top collaborators of Mary E. Heber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary E. Heber. Mary E. Heber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vohra, Hunaid A., et al.. (2006). Sutureless off-pump repair of post-infarction left ventricular free wall rupture. Journal of Cardiothoracic Surgery. 1(1). 11–11. 5 indexed citations
2.
Grainge, Christopher & Mary E. Heber. (2005). The Role Of The Physician In Modern Military Operations: 12 Months Experience In Southern Iraq. Journal of the Royal Army Medical Corps. 151(2). 101–104. 15 indexed citations
3.
Heber, Mary E., et al.. (1996). Ambulatory intraarterial blood pressure in essential hypertension*Effects of age, sex, race, and body mass—the northwick park hospital database study. American Journal of Hypertension. 9(10). 943–952. 29 indexed citations
4.
Raftery, E. B., et al.. (1991). 24-Hour Blood Pressure Control with the Once-Daily Calcium Antagonist Amlodipine. Journal of Cardiovascular Pharmacology. 17(Supplement 1). S8–S12. 18 indexed citations
5.
Heber, Mary E., et al.. (1990). Valvular tuberculous endocarditis: A case report and review of the literature. Journal of Infection. 21(3). 293–296. 19 indexed citations
6.
Broadhurst, Paul, et al.. (1990). Twenty-four hour ambulatory blood pressure profile of a new, sustained-release preparation of nicardipine. Cardiovascular Drugs and Therapy. 4(2). 435–438. 5 indexed citations
7.
Heber, Mary E., et al.. (1990). Effectiveness of the once-daily calcium antagonist, lacidipine, in controlling 24-hour ambulatory blood pressure. The American Journal of Cardiology. 66(17). 1228–1232. 10 indexed citations
8.
Heber, Mary E., et al.. (1989). Once daily nisoldipine in hypertension: cuff and ambulatory intra-arterial blood pressure. European Journal of Clinical Pharmacology. 37(6). 551–554. 2 indexed citations
9.
Wilkins, Robert A., et al.. (1989). Safety and Pharmacokinetics of Ioversol in Healthy Volunteers. Investigative Radiology. 24(10). 781–788. 14 indexed citations
10.
Hughes, Liam O., et al.. (1989). Haemodynamic advantage of the Valsalva manoeuvre during heavy resistance training. European Heart Journal. 10(10). 896–902. 5 indexed citations
11.
Wilkins, Robert A., et al.. (1989). Safety and Pharmacokinetics of Ioversol in Healthy Volunteers. Investigative Radiology. 24(Supplement 1). S28–S28. 1 indexed citations
12.
Heber, Mary E., Edward B. Raftery, & D S Thompson. (1988). Intra-arterial ambulatory blood pressure monitoring can save your life — or, acute haemodynamic response to a murderous assault. International Journal of Cardiology. 20(1). 138–141. 3 indexed citations
13.
Heber, Mary E., et al.. (1988). First dose response and 24-hour antihypertensive efficacy of the new once-daily angiotensin converting enzyme inhibitor, ramipril. The American Journal of Cardiology. 62(4). 239–245. 12 indexed citations
14.
Lahiri, Avijit, et al.. (1988). Effects of Carvedilol on Left Ventricular Function in Essential Hypertension and Ischaemic Heart Disease1. Drugs. 36(Supplement 6). 141–143. 2 indexed citations
15.
Heber, Mary E., et al.. (1988). Is there a relationship between ambulatory intra-arterial blood pressure and left ventricular function?. Hypertension. 11(5). 464–469. 5 indexed citations
16.
Caruana, M., et al.. (1987). Assessment of ‘once daily’ verapamil for the treatment of hypertension using ambulatory, intra-arterial blood pressure recording. European Journal of Clinical Pharmacology. 32(6). 549–553. 16 indexed citations
17.
Heber, Mary E., et al.. (1987). Carvedilol for Systemic Hypertension*. Journal of Cardiovascular Pharmacology. 10. S113–S118. 7 indexed citations
18.
Heber, Mary E., Robert D. Vincent, & D A Chamberlain. (1984). Sublingual glyceryl trinitrate compared with Nitrolingual spray using cardiac scintigraphy.. BMJ. 289(6454). 1269.2–1270. 2 indexed citations
19.
Jaggarao, N S V, Mary E. Heber, R.M. Grainger, et al.. (1982). Use of an automated external de fibrillation pacemaker by ambulance staff. The Lancet. 2(8289). 73–75. 152 indexed citations
20.
Heber, Rick & Mary E. Heber. (1957). The effect of group failure and success on social status.. Journal of Educational Psychology. 48(3). 129–134. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. Hempelmann Breakdown of academic impact, for papers by Willehad Boemke Breakdown of academic impact, for papers by Leonard C. Jenkins Breakdown of academic impact, for papers by D. Emslie-Smith Breakdown of academic impact, for papers by A A McLeod Breakdown of academic impact, for papers by P Huguenard Breakdown of academic impact, for papers by John C. Mithoefer Breakdown of academic impact, for papers by K Steinbereithner Breakdown of academic impact, for papers by Stephen M. Koch Breakdown of academic impact, for papers by Leonard F. Walts
Rankless by CCL
2026